Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose Derived MSCs for Pulmonary Arterial Hypertension
NCT04055415Phase 2Unknown
- Sponsor
- Liaocheng City People's Hospital
- Start
- Aug 2019
- Primary completion
- Aug 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of adipose derived mesenchymal stromal cells in pulmonary hypertension (PH), chronic obstructive pulmonary disease (COPD), sponsored by Liaocheng City People's Hospital. Status: unknown.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
pulmonary hypertension (PH)chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04055415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04055415.